Last quarter (Q3 2024), Biosyent's total revenue was $9.56M, an increase of 7.72% from the same quarter last year. In Q3, Biosyent's net income was $2.31M. See Biosyent’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 34.51M	$ 31.59M	$ 27.93M	$ 28.62M	$ 22.33M	$ 21.42M
Cost of Revenue	$ 7.10M	$ 5.99M	$ 5.07M	$ 5.98M	$ 4.91M	$ 4.78M
Gross Profit	$ 27.41M	$ 25.60M	$ 22.86M	$ 22.64M	$ 17.42M	$ 16.65M
Operating Expense	$ 19.23M	$ 18.13M	$ 15.95M	$ 14.39M	$ 12.30M	$ 10.28M
Operating Income	$ 8.18M	$ 7.47M	$ 6.91M	$ 8.25M	$ 5.13M	$ 6.37M
Net Non Operating Interest Income Expense	$ 1.11M	$ 1.06M	$ 448.65K	$ -51.80K	$ -170.19K	$ -414.56K
Other Income Expense	$ -63.11K	$ -63.11K	$ ―	$ 78.99K	$ -58.83K	$ -911.44K
Pretax Income	$ 9.39M	$ 8.53M	$ 7.28M	$ 8.38M	$ 5.24M	$ 5.87M
Tax Provision	$ 2.28M	$ 2.07M	$ 1.97M	$ 2.10M	$ 1.44M	$ 1.50M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 7.11M	$ 6.46M	$ 5.31M	$ 6.28M	$ 3.80M	$ 4.37M
Basic EPS	$ 0.61	$ 0.54	$ 0.44	$ 0.50	$ 0.29	$ 0.31
Diluted EPS	$ 0.60	$ 0.53	$ 0.44	$ 0.49	$ 0.29	$ 0.31
Basic Average Shares	$ 46.64M	$ 11.95M	$ 12.30M	$ 12.69M	$ 12.98M	$ 13.95M
Diluted Average Shares	$ 47.49M	$ 12.17M	$ 12.54M	$ 12.87M	$ 13.09M	$ 13.95M
Dividend Per Share	$ 0.20	$ 0.04	$ 0.04	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 26.33M	$ 24.12M	$ 21.02M	$ -20.37M	$ -17.21M	$ -15.06M
Net Income From Continuing And Discontinued Operation	$ 7.11M	$ 6.46M	$ 5.31M	$ 6.28M	$ 3.80M	$ 4.37M
Normalized Income	$ 8.82M	$ 6.27M	$ 5.35M	$ 6.16M	$ 3.85M	$ 5.22M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ 9.45M	$ 8.60M	$ 7.36M	$ 8.46M	$ 5.33M	$ 5.90M
EBITDA	$ 9.92M	$ 9.06M	$ 7.81M	$ 8.92M	$ 5.84M	$ 6.19M

Currency in USD

Biosyent Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing